Publicado: Jue, May 10, 2018
Salud | Por Gertrudes Rodriquez

USPSTF: Final Recommendation Statement on Prostate Cancer Screening

USPSTF: Final Recommendation Statement on Prostate Cancer Screening

A task force said men 55 to 69 who want to be screened should discuss it with their doctor. A recommendation issued Tuesday by the U.S. Preventive Services Task Force judged the "net benefits" of screening these men for prostate cancer to be small.

"While we know that African American men and men with a family history are more likely to get prostate cancer and more likely to die from prostate cancer, we don't know if screening offers them any greater benefit", Krist said.

Men over 70 are advised against screening because the harms of testing outweigh the benefits. Six years ago, the USA... Like the USPSTF, the AUA acknowledges there is limited evidence surrounding the benefits and risks of prostate cancer testing in men over 70, and we too support the call for increased research to fill the evidence gaps and better inform recommendations for these individuals. "It's not about more testing - it's about screening smarter and identifying disease at the earliest possible stage", said Alan W. Partin, M.D., Ph.D., PCEC council member and chairman of the Department of Urology at Johns Hopkins.

Primeros contactos entre Central y Bauza
En declaraciones a radio El Mundo, el " Patón " Bauza señaló: " Sé que Central me quiere, pero todavía no me junté con los dirigentes".

But there is no evidence that prostate cancer screening improves overall survival.

According to results of clinical studies, prostate cancer screening with the PSA (prostate-specific antigen) blood test could prevent approximately 1.3 deaths from prostate cancer over 13 years per 1,000 men screened. Its new guidance, echoing other groups' advice and affirming its draft recommendations issued previous year, was published Tuesday in the Journal of the American Medical Association. Dr. Sandler is a professor and chair of radiation oncology and directs the comprehensive cancer institute at Cedars-Sinai in Los Angeles.

With the new recommendation, doctors should help with the decision-making process by providing patients with information.

Me gusta esto: